MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image PROGENICS PHARMACEUTICALS
PROGENICS PHARMACEUTICALS

PROGENICS PHARMACEUTICALS

Summary

Progenics Pharmaceuticals is an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer.

Deals Overview

Total Deals1
Valued Deals1
Total Value£ 423 M
Avg. Deal Size£ 423 M

Market Context

Senior Management

  • Mark Baker

    Mark Baker

    CEO

  • James Golden

    James Golden

Sort

jg

james golden

PROGENICS PHARMACEUTICALS

Manager

1

Deal

£ 423 M

Total Value

mb

mark baker

CEO at PROGENICS PHARMACEUTICALS

Manager

1

Deal

£ 423 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite